Relevant concomitant medications included insulin (100%), statins (19%), angiotensin converting enzyme inhibitors (5%) and the anti‐obesity agent phenmetrazine hydrochloride (5%). Here, ACE is linked to obesity due to melanocortin 4 receptor deficiency.